1 Dec 2016
Business briefs
The listed drug manufacturer, AFT Pharmaceuticals, says its sinus treatment device, NasoSURF, has been registered in the United States, which is a first step to full commercialisation of the product.
The listed drug manufacturer, AFT Pharmaceuticals, says its sinus treatment device, NasoSURF, has been registered in the United States, which is a first step to full commercialisation of the product.